Você está na página 1de 4

NAME: CHARMEN D.

COROWAN BSPH-4 SCORE: ________________

_____________________________________________

GENERIC
MECHANISM OF ADVERSE DRUG
CLASS NAME/BRAND PHARMACOKINETICS ANTIDOTE
ACTION REACTION INTERACTION
NAME
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
_____________
_____________
__________________ _______________________ ___________________________ ______________ _________________
_____________
__________________ _______________________ ___________________________ ______________ _________________
_____________
__________________ _______________________ ___________________________ ______________ _________________
_____________
__________________ _______________________ ___________________________ ______________ _________________
_____________
__________________ _______________________ ___________________________ ______________ _________________
_____________
__________________ _______________________ ___________________________ ______________ _________________
_____________
__________________ _______________________ ___________________________ ______________ _________________
__________________ _______________________ ___________________________ ______________ _________________
GENERIC
MECHANISM OF ADVERSE DRUG
CLASS NAME/BRAND PHARMACOKINETICS ANTIDOTE
ACTION REACTION INTERACTION
NAME
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________
__________________ _______________________ ___________________________ ______________ _________________ _____________

Você também pode gostar